{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:27:24Z","timestamp":1745918844069},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00120-012-3083-3","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T11:21:46Z","timestamp":1359631306000},"page":"186-192","source":"Crossref","is-referenced-by-count":4,"title":["\u00c4tiologie und Pathophysiologie der benignen Prostatahyperplasie"],"prefix":"10.1007","volume":"52","author":[{"given":"A.","family":"Roosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Herrlemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Magistro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tritschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,2]]},"reference":[{"key":"3083_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000475324","volume":"25","author":"Isaacs","year":"1994","unstructured":"Isaacs JT (1994) Etiology of benign prostatic hyperplasia. Eur Urol 25(Suppl 1):6\u20139","journal-title":"Eur Urol"},{"key":"3083_CR2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2005-1947","volume":"91","author":"Marberger","year":"2006","unstructured":"Marberger M, Roehrborn CG, Marks LS (2006) Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. J Clin Endocrinol Metab 91(4):1323\u20131328","journal-title":"J Clin Endocrinol Metab"},{"key":"3083_CR3","first-page":"340","volume":"15","author":"McNeal","year":"1978","unstructured":"McNeal JE (1978) Origin and evolution of benign prostatic enlargement. Invest Urol 15(4):340\u2013345","journal-title":"Invest Urol"},{"key":"3083_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pros.10204","volume":"55","author":"Castro","year":"2003","unstructured":"Castro P, Giri D, Lamb D, Ittmann M (2003) Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55(1):30\u201338","journal-title":"Prostate"},{"key":"3083_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.urology.2007.11.083","volume":"72","author":"Schauer","year":"2008","unstructured":"Schauer IG, Rowley DR (2008) Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72(1):205\u2013213","journal-title":"Urology"},{"key":"3083_CR6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1464-410X.2006.06133.x","volume":"97","author":"Khadra","year":"2006","unstructured":"Khadra A, Fletcher P, Luzzi G et al (2006) Interleukin-8 levels in seminal plasma in chronic prostatitis\/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 97(5):1043\u20131046","journal-title":"BJU Int"},{"key":"3083_CR7","doi-asserted-by":"crossref","unstructured":"Macoska JA (2011) Chemokines and BPH\/LUTS. Differentiation 82(4\u20135):253\u2013260","DOI":"10.1016\/j.diff.2011.04.003"},{"key":"3083_CR8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"Kramer","year":"2007","unstructured":"Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5):1202\u20131216","journal-title":"Eur Urol"},{"key":"3083_CR9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.juro.2008.01.034","volume":"179","author":"Delongchamps","year":"2008","unstructured":"Delongchamps NB, de la Roza G, Chandan V et al (2008) Evaluation of prostatitis in autopsied prostates \u2013 is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 179(5):1736\u20131740","journal-title":"J Urol"},{"key":"3083_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1464-410X.2007.06910.x","volume":"100","author":"Mishra","year":"2007","unstructured":"Mishra VC, Allen DJ, Nicolaou C et al (2007) Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 100(2):327\u2013331","journal-title":"BJU Int"},{"key":"3083_CR11","doi-asserted-by":"crossref","unstructured":"Nicholson TM, Ricke WA (2011) Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation 82(4\u20135):184\u2013199","DOI":"10.1016\/j.diff.2011.04.006"},{"key":"3083_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pros.20080","volume":"61","author":"Roberts","year":"2004","unstructured":"Roberts RO, Jacobson DJ, Rhodes T et al (2004) Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 61(2):124\u2013131","journal-title":"Prostate"},{"key":"3083_CR13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/pcan.2008.50","volume":"12","author":"Hammarsten","year":"2009","unstructured":"Hammarsten J, Damber JE, Karlsson M et al (2009) Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 12(2):160\u2013165","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3083_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.2009.04360.x","volume":"1155","author":"Ellem","year":"2009","unstructured":"Ellem SJ, Risbridger GP (2009) The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 1155:174\u2013186","journal-title":"Ann N Y Acad Sci"},{"key":"3083_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2010.05.001","volume":"21","author":"Sugiyama","year":"2010","unstructured":"Sugiyama N, Barros RP, Warner M et al (2010) ER\u00a0beta: recent understanding of estrogen signaling. Trends Endocrinol Metab 21(9):545\u2013552","journal-title":"Trends Endocrinol Metab"},{"key":"3083_CR16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/aja.2010.24","volume":"12","author":"Yang","year":"2010","unstructured":"Yang R, Ma YX, Chen LF et al (2010) Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia. Asian J Androl 12(5):735\u2013743","journal-title":"Asian J Androl"},{"key":"3083_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","volume":"51","author":"Ozden","year":"2007","unstructured":"Ozden C, Ozdal OL, Urgancioglu G et al (2007) The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 51(1):199\u2013206","journal-title":"Eur Urol"},{"key":"3083_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","volume":"101","author":"Parsons","year":"2008","unstructured":"Parsons JK, Bergstrom J, Barrett-Connor E (2008) Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int 101(3):313\u2013318","journal-title":"BJU Int"},{"key":"3083_CR19","doi-asserted-by":"crossref","unstructured":"Wang Z, Olumi AF (2011) Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation 82(4\u20135):261\u2013271","DOI":"10.1016\/j.diff.2011.04.004"},{"key":"3083_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1096-4959(02)00160-4","volume":"134","author":"Pertseva","year":"2003","unstructured":"Pertseva MN, Shpakov AO, Plesneva SA et al (2003) A novel view on the mechanisms of action of insulin and other insulin superfamily peptides: involvement of adenylyl cyclase signaling system. Comp Biochem Physiol B Biochem Mol Biol 134(1):11\u201336","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"3083_CR21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2353\/ajpath.2007.070285","volume":"171","author":"Li","year":"2007","unstructured":"Li W, Wu CL, Febbo PG et al (2007) Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Am J Pathol 171(4):1189\u20131198","journal-title":"Am J Pathol"},{"key":"3083_CR22","first-page":"1081","volume":"61","author":"Landsberg","year":"1986","unstructured":"Landsberg L (1986) Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 61(236):1081\u20131090","journal-title":"Q J Med"},{"key":"3083_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.14.99","volume":"14","author":"Davis","year":"2007","unstructured":"Davis HR, Veltri EP (2007) Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J Atheroscler Thromb 14(3):99\u2013108","journal-title":"J Atheroscler Thromb"},{"key":"3083_CR24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/cdd.2009.148","volume":"17","author":"Jiang","year":"2010","unstructured":"Jiang M, Fernandez S, Jerome WG et al (2010) Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ 17(3):469\u2013481","journal-title":"Cell Death Differ"},{"key":"3083_CR25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(01)65069-9","volume":"157","author":"Sanda","year":"1997","unstructured":"Sanda MG, Beaty TH, Stutzman RE et al (1997) Clinical and biological characteristics of familial benign prostatic hyperplasia. J Urol 157(3):876\u2013879","journal-title":"J Urol"},{"key":"3083_CR26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0090-4295(02)02509-8","volume":"61","author":"Pearson","year":"2003","unstructured":"Pearson JD, Lei HH, Beaty TH et al (2003) Familial aggregation of bothersome benign prostatic hyperplasia symptoms. Urology 61(4):781\u2013785","journal-title":"Urology"},{"key":"3083_CR27","doi-asserted-by":"crossref","unstructured":"Hocaoglu Y, Herrmann K, Walther S et al (2013) Contraction of the anterior prostate is required for the initiation of micturition. BJU (in press)","DOI":"10.1111\/j.1464-410X.2012.11698.x"},{"key":"3083_CR28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.urology.2007.10.051","volume":"71","author":"Uckert","year":"2008","unstructured":"Uckert S, Schultheiss D, Geismar U et al (2008) Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue. Urology 71(3):526\u2013530","journal-title":"Urology"},{"key":"3083_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000280347","volume":"35","author":"Gosling","year":"1980","unstructured":"Gosling JA, Dixon JS (1980) Structure of trabeculated detrusor smooth muscle in cases of prostatic hypertrophy. Urol Int 35(5):351\u2013355","journal-title":"Urol Int"},{"key":"3083_CR30","first-page":"7","volume":"4","author":"Steers","year":"2002","unstructured":"Steers WD (2002) Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4(Suppl 4):7\u201318","journal-title":"Rev Urol"},{"key":"3083_CR31","doi-asserted-by":"crossref","unstructured":"Jiang M, Strand DW, Franco OE et al (2011) PPAR\u03b3: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation 82(4\u20135):181\u2013123","DOI":"10.1016\/j.diff.2011.05.008"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-012-3083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-012-3083-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-012-3083-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T02:45:29Z","timestamp":1562640329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-012-3083-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["3083"],"URL":"https:\/\/doi.org\/10.1007\/s00120-012-3083-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}